MS
HOOK

Maven Securities’s HOOKIPA Pharma HOOK Stock Holding History

Maven Securities’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,604
Closed -$129K – 1149
2023
Q2 		$129K Buy
+14,604
New +$162K ﹤0.01% 830
2021
Q2 		– Sell
-4,892
Closed -$661K – 1169
2021
Q1 		$661K Buy
+4,892
New +$590K 0.03% 551

Other funds holding HOOK

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Maven Securities's HOOK Position: Q3 2023 in Review

Maven Securities sold out of HOOKIPA Pharma (HOOK) in Q3 2023, closing a stake of 14,604 shares — an estimated $129K sold.

Maven Securities first reported a position in HOOK in Q1 2021 and held it in 2 quarters. The position peaked at $661K in Q1 2021. 44 funds tracked by Wall St. Rank hold HOOK as of Q3 2023.

  • Maven Securities reported no remaining HOOKIPA Pharma position as of Q3 2023 after selling out during the quarter.
  • Maven Securities sold 14,604 HOOKIPA Pharma shares in Q3 2023, an estimated $129K.
  • Maven Securities first reported a position in HOOKIPA Pharma in Q1 2021 and held it in 2 quarters.
  • Maven Securities's HOOKIPA Pharma position peaked at $661K in Q1 2021.
  • 44 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2023.

Based on Maven Securities's 13F filing for Q3 2023, filed 13 Nov 2023.